The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Amphetamine-Related Disorders

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Amphetamine-Related Disorders


Psychiatry related information on Amphetamine-Related Disorders


High impact information on Amphetamine-Related Disorders


Chemical compound and disease context of Amphetamine-Related Disorders


Gene context of Amphetamine-Related Disorders

  • It would appear that the medical complications associated with amphetamine addiction are not relevant to the therapeutic use of stimulant medication in the treatment of ADHD, although there is limited information on extended periods of treatment lasting 10 years or more [18].
  • The results suggest that NPFF may modulate the neuronal process of amphetamine addiction [19].
  • Although desipramine clearly was no more effective than placebo in treatment of PCP dependence, subjects with amphetamine dependence who received desipramine remained in treatment longer and submitted more urine samples absent of amphetamine than did subjects who received placebo [20].
  • Therefore, it seems that selective adenosine A1 receptor agonists may have some attenuating influence on the development of amphetamine dependence [21].

Analytical, diagnostic and therapeutic context of Amphetamine-Related Disorders


  1. Cerebral vasculitis following oral methylphenidate intake in an adult: a case report. Thomalla, G., Kucinski, T., Weiller, C., Röther, J. World J. Biol. Psychiatry (2006) [Pubmed]
  2. Nutritional status of deceased illicit drug addicts in Stockholm, Sweden--a longitudinal medicolegal study. Rajs, J., Petersson, A., Thiblin, I., Olsson-Mortlock, C., Fredriksson, A., Eksborg, S. J. Forensic Sci. (2004) [Pubmed]
  3. Modafinil for social phobia and amphetamine dependence. Camacho, A., Stein, M.B. The American journal of psychiatry. (2002) [Pubmed]
  4. Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component. Schuckit, M.A., Daeppen, J.B., Danko, G.P., Tripp, M.L., Smith, T.L., Li, T.K., Hesselbrock, V.M., Bucholz, K.K. The American journal of psychiatry. (1999) [Pubmed]
  5. Volunteer bias in a study of male alcoholics' sexual behavior. Nirenberg, T.D., Wincze, J.P., Bansal, S., Liepman, M.R., Engle-Friedman, M., Begin, A. Archives of sexual behavior. (1991) [Pubmed]
  6. Depressive symptoms among amphetamine and cocaine users before and after substance abuse treatment. Riehman, K.S., Iguchi, M.Y., Anglin, M.D. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. (2002) [Pubmed]
  7. Combined dopamine and serotonin agonists: a synergistic approach to alcoholism and other addictive behaviors. Hitzig, P. Maryland medical journal (Baltimore, Md. : 1985) (1993) [Pubmed]
  8. Acute cardiomyopathy secondary to intravenous amphetamine abuse. Call, T.D., Hartneck, J., Dickinson, W.A., Hartman, C.W., Bartel, A.G. Ann. Intern. Med. (1982) [Pubmed]
  9. Amphetamine-induced hyperthyroxinemia. Morley, J.E., Shafer, R.B., Elson, M.K., Slag, M.F., Raleigh, M.J., Brammer, G.L., Yuwiler, A., Hershman, J.M. Ann. Intern. Med. (1980) [Pubmed]
  10. Intracerebral hemorrhage and vasculitis related to ephedrine abuse. Wooten, M.R., Khangure, M.S., Murphy, M.J. Ann. Neurol. (1983) [Pubmed]
  11. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Rogers, R.D., Everitt, B.J., Baldacchino, A., Blackshaw, A.J., Swainson, R., Wynne, K., Baker, N.B., Hunter, J., Carthy, T., Booker, E., London, M., Deakin, J.F., Sahakian, B.J., Robbins, T.W. Neuropsychopharmacology (1999) [Pubmed]
  12. Bupropion: clinical assay for amphetamine-like abuse potential. Griffith, J.D., Carranza, J., Griffith, C., Miller, L.L. The Journal of clinical psychiatry. (1983) [Pubmed]
  13. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Van Kammen, D.P., Murphy, D.L. Psychopharmacologia. (1975) [Pubmed]
  14. Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Shearer, J., Wodak, A., Mattick, R.P., Van Beek, I., Lewis, J., Hall, W., Dolan, K. Addiction (2001) [Pubmed]
  15. D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine. Chiang, Y.C., Chen, P.C., Chen, J.C. Brain Res. (2003) [Pubmed]
  16. The development and initial validation of a questionnaire to measure craving for amphetamine. James, D., Davies, G., Willner, P. Addiction (2004) [Pubmed]
  17. The use of benzodiazepines among regular amphetamine users. Darke, S., Ross, J., Cohen, J. Addiction (1994) [Pubmed]
  18. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder. Poulton, A. Expert review of neurotherapeutics. (2006) [Pubmed]
  19. Neuropeptide FF potentiates the behavioral sensitization to amphetamine and alters the levels of neurotransmitters in the medial prefrontal cortex. Chen, J.C., Li, J.Y., Liang, K.W., Huang, Y.K. Brain Res. (1999) [Pubmed]
  20. Double-blind comparison of desipramine and placebo for treatment of phencyclidine or amphetamine dependence. Tennant, F.S., Tarver, A., Pumphrey, E., Seecof, R. NIDA Res. Monogr. (1986) [Pubmed]
  21. Effects of adenosine receptor agonists and antagonists in amphetamine-induced conditioned place preference test in rats. Poleszak, E., Malec, D. Polish journal of pharmacology. (2003) [Pubmed]
WikiGenes - Universities